ALB and hepatocellular carcinoma: Another study conducted by Peng et al. [133] revealed that a high pre-treatment serum aspartate aminotransferase (AST)/ALB ratio was a factor that was independently correlated with worse OS and RFS in HCC patients undergoing curative surgical resection.